Recovery of BMIPP uptake and regional wall motion in insulin resistant patients following angioplasty for acute myocardial infarction

Circulation Journal

Volumn 67, Issue 9, 2003, Pages 757-762

  Fujino, Takayuki ^a,b   Ishii, Yoshinao ^a   Takeuchi, Toshiharu ^b   Hirasawa, Kunihiko ^a   Tateda, Kunihiko ^a   Kikuchi, Kenjiro ^b   Hasebe, Naoyuki ^b  

^a ASAHIKAWA CITY HOSPITAL   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Acute myocardial infarction; Fatty acid metabolism; Insulin resistance; Wall motion abnormality

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; INSULIN; THALLIUM 201;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORRELATION ANALYSIS; DRUG UPTAKE; FATTY ACID METABOLISM; FEMALE; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE; HEART MUSCLE REPERFUSION; HEART VENTRICULOGRAPHY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; RADIOISOTOPE VENTRICULOGRAPHY;

EID: 0042821498     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.67.757     Document Type: Article

References (37)

1. Alberti KG. The clinical implications of impaired glucose tolerance. Diabet Med 1996; 13: 927-937.
2. International Collaborative Group. Asymptomatic Hyperglycemia and Coronary Heart Disease: A series of papers by the International Collaborative Group based on studies in fifteen populations. J Chron Dis 1979; 32: 681-837.
3. Fontbonne A, Eschwege E, Cambien F. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 1989; 32: 300-304.
4. Stengard JH, Tuomilehto J, Pekkanen J. Diabetes mellitus, impaired glucose tolerance and mortality among elderly men: The Finnish cohorts of the seven countries study. Diabetologia 1992; 35: 760-765.
5. Rewers M, Shetterly SM, Baxter J. Prevalence of coronary heart disease in subjects with normal and impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a Biethnic Colorado Population: The San Luis Valley Diabetes Study. Am J Epidemiol 1992; 135: 1321-1330.
6. Rodrigues B, McNeill JH. The diabetic heart: Metabolic causes for the development of a cardiomyopathy. Cardiovasc Res 1992; 26: 913-922.
7. Stanley WC, Lopaschuk GD, McCormack JG. Regulation of energy substrate metabolism in the diabetic heart. Cardiovas Res 1997; 34: 25-33.
8. Turpeinen AK, Knikka JT, Vanninen E. Abnormal myocardial kinetics of 123I-heptadecanoic acid in subjects with impaired glucose tolerance. Diabetologia 1997; 40: 541-549.
9. Turpeinen AK, Takala TO, Nuutila P, Axelin T, Luotolahti M, Haaparanta M, et al. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: Studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid. Diabetes 1999; 48: 1245-1250.
10. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction: The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med. 1993; 328: 673-679.
11. Aronson D, Rayfield EJ, Chesebro JH. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med 1997; 126: 296-306.
12. Zuanetti G, Latini R, the GISSI-3 investigators. Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: Data from the GISSI-3 study. Circulation 1997; 96: 4239-4245.
13. Ito H, Taniyama Y, Iwakura K. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 1999; 33: 654-660.
14. Gross GJ, Yao Z, Pieper GM. The ATP-regulated potassium channel in ischemia-reperfusion injury. Ann NY Acad Sci 1994; 723: 71-81.
15. Apstein CS. Glucose-insulin-potassium for acute myocardial infarction: Remarkable results from a new prospective, randomized trial. Circulation 1998; 98: 2223-2226.
16. The TIMI study group. The thrombolysis in myocardial infarction (TIMI) trial: Phase 1 findings. N Engl J Med 1984; 33: 523-530.
17. World Health Organization Study Group on Diabetes Mellitus. Technical report series 727. Geneva: WHO, 1985.
18. Phillips DIW, Clark PM, Hales CN. Understanding oral glucose tolerance: Comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 1994; 11: 286-292.
19. Matthews DR, Hosker JP, Rudenski AS. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
20. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57-63.
21. 123I-15-iodophenyl 3-methyl pentadecanoic acid/201T1 myocardial single photon emission computed tomography. Circ J 2001; 65: 769-774.
22. Sandler H, Dodge HT. The use of single plane angiocardiograms for the calculation of left ventricular volume in man. Am Heart J 1968; 75: 325-334.
23. Sheehan FH, Bolson EL, Dodge HT. Advantages and applications of the centerline method for characterizing regional ventricular function. Circulation 1986; 74: 293-305.
24. Matsuda M, DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 1999; 22: 1462-1470.
25. Yanagisawa H, Chikamori T, Tanaka N, Hatano T, Morishima T, Hida S, et al. Correlation between thallium-201 myocardial perfusion defects and the functional severity of coronary artery stenosis as assessed by pressure-derived myocardial fractional flow reserve. Circ J 2002; 66: 1105-1109.
26. Marinho NVS, Keogh BE, Costa DC. Pathophysiology of chronic left ventricular dysfunction: New insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation 1996; 93: 737-744.
27. Jonassen AK, Sack MN, Mjos OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 2001; 89: 1191-1198.
28. Lind L, Andersson PE, Andren B. Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome. J Hypertens 1995; 13: 433-438.
29. Koren MJ, Devereux RB, Casale PN. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-352.
30. Frayn KN. Insulin resistance and lipid metabolism. Curr Opin Lipidol 1993; 4: 197-204.
31. Nuutila P, Knuuti J, Ruotsalainen U. Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes. Am J Physiol 1993; 264: E756-E762.
32. Paternostro G, Camici PG, Lammerstma AA. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease: A study with positron emission tomography. J Clin Invest 1996; 98: 2094-2099.
33. Voipio-pulkki LM, Nuutila P, Knuuti J. Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography. J Nucl Med 1993; 34: 2064-2067.
34. Kurata C, Wakabayashi Y, Shouda S. Influence of blood substrate levels on myocardial kinetics of iodine-123-BMIPP. J Nucl Med 1997; 38: 1079-1084.
35. Nuutila P, Koivisto VA, Knuuti J. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest 1992; 89: 1767-1774.
36. Ginsberg HN. Treatment for patients with the metabolic syndrome. Am J Cardiol 2003; 91: 29E-39E.
37. Scherrer U, Sartori C. Insulin as a vascular and sympathoexcitatory hormone: Implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 1997; 96: 4104-4113.